DigestRedComo funciona
Red
/
Empresas
Ve
No verificado

Vedanta Biosciences

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
09/04/2026
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Vedanta Biosciences Showcases Innovative Work on its Microbiome-based Therapeutics at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 Global Congress
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0
02/04/2026
Industria
Higiene alimentaria
Salud
VIH, SIDA y enfermedades autoinmunes
Medicina - Varios
Farmacéutica
Biotecnología
Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0
13/08/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0
23/01/2025
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0
16/10/2024
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0
23/07/2024
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
Fuente
Vedanta Biosciences
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0